When, where, and how to target vascular inflammation in the post-CANTOS era?

Eur Heart J. 2019 Aug 7;40(30):2492-2494. doi: 10.1093/eurheartj/ehz133.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Anti-Inflammatory Agents
  • Atherosclerosis*
  • Humans
  • Inflammation
  • Interleukin-1*
  • Protein Isoforms

Substances

  • Anti-Inflammatory Agents
  • Interleukin-1
  • Protein Isoforms